DAKO 22C3 evaluated the PD-L1 positivity by using a combined positive score (CPS), defined as the number of PD-L1-stained cells (tumor cells, lymphocytes and macrophages) divided by the total number of viable tumor cells multiplied by 100. The gene discussed is CD274; the disease is neoplasm.